Zai Lab Limited (ZLAB) Financials
ZLAB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.0 billion | 240.2 million |
2023-09-30 | 1.0 billion | 162.7 million |
2023-06-30 | 1.1 billion | 174.1 million |
2023-03-31 | 1.2 billion | 168.8 million |
ZLAB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -15.8 million | 20.5 million |
2023-09-30 | -57.1 million | 22.0 million |
2023-06-30 | -61.1 million | 20.5 million |
2023-03-31 | -72.8 million | 16.7 million |
ZLAB Net Income
No data available :(
ZLAB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 806.5 million | - | 15.2 million |
2023-09-30 | 820.4 million | - | 16.7 million |
2023-06-30 | 874.7 million | - | 19.1 million |
2023-03-31 | 930.4 million | - | 20.3 million |
ZLAB Shares Outstanding
ZLAB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 843000 | 81.9 million | 82.6 million | - |
2023-09-30 | 1.8 million | 58.8 million | 68.6 million | - |
2023-06-30 | 2.3 million | 76.7 million | 67.9 million | - |
2023-03-31 | 3.5 million | 48.5 million | 62.5 million | - |
ZLAB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 65.8 million | 25.2 million |
2023-09-30 | 69.2 million | 25.5 million |
2023-06-30 | 68.9 million | 23.8 million |
2023-03-31 | 62.8 million | 21.3 million |
ZLAB
Price: $16.25
52 week price:
Earnings Per Share: -3.50 USD
P/E Ratio: -6.03
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 84585
Market Capitalization: 1.4 billion